Enorama Pharma AB (publ)

OM:ERMA Stock Report

Market Cap: SEK 228.0m

Enorama Pharma Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Daniel Schroder

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Daniel Schroder (41 yo)

less than a year

Tenure

Mr. Daniel Schroder is a Director of Enorama Pharma AB (publ) since 2023 and serves as its Chief Executive Officer since August 2024. Mr. Schroder holds a MSc in Business and Economics from Uppsala Univers...

Board Members

NamePositionTenureCompensationOwnership
Daniel Schroder
CEO & Director1.8yrsno datano data
Mats Rönngard
Board Memberless than a yearno datano data
Bengt Jönsson
Chairman of the Boardless than a yearno data0.0018%
SEK 4.1k
Fredrik Olsson
Director1.8yrsno data0.86%
SEK 2.0m
Tanu Tandan
Board Memberless than a yearno datano data
Ara Abrahamian
Board Memberless than a yearno datano data

0.8yrs

Average Tenure

62yo

Average Age

Experienced Board: ERMA's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.